Published in Clin Infect Dis on October 04, 2001
Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev (2005) 3.27
Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis (2002) 3.07
Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis (2004) 2.35
Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis (2003) 2.06
Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus. Emerg Infect Dis (2002) 1.77
Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob Agents Chemother (2002) 1.71
Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother (2009) 1.26
Antimicrobial resistance in hospitals: how concerned should we be? CMAJ (2009) 1.16
Development and assessment of a questionnaire for a descriptive cross-sectional study concerning parents' knowledge, attitudes and practises in antibiotic use in Greece. BMC Infect Dis (2009) 1.06
Antibiotics, resistance, and clinical outcomes. BMJ (2004) 1.02
Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance. Clin Microbiol Rev (2013) 1.01
Colonization and resistance dynamics of gram-negative bacteria in patients during and after hospitalization. Antimicrob Agents Chemother (2005) 0.99
Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases. Infection (2016) 0.97
Fluoroquinolones protective against cephalosporin resistance in gram-negative nosocomial pathogens. Emerg Infect Dis (2004) 0.96
Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients. Antimicrob Agents Chemother (2010) 0.93
An overview of harms associated with beta-lactam antimicrobials: where do the carbapenems fit in? Crit Care (2008) 0.92
Trends and correlation of antibacterial usage and bacterial resistance: time series analysis for antibacterial stewardship in a Chinese teaching hospital (2009-2013). Eur J Clin Microbiol Infect Dis (2014) 0.91
Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use. Emerg Infect Dis (2005) 0.90
Fluoroquinolone use and fluoroquinolone-resistant Pseudomonas aeruginosa is declining in US academic medical centre hospitals. J Antimicrob Chemother (2012) 0.89
Improving quinolone use in hospitals by using a bundle of interventions in an interrupted time series analysis. Antimicrob Agents Chemother (2010) 0.88
Antimicrobial agent exposure and the emergence and spread of resistant microorganisms: issues associated with study design. Eur J Clin Microbiol Infect Dis (2012) 0.85
Emergence and acquisition of fluoroquinolone-resistant gram-negative bacilli in the intestinal tracts of mice treated with fluoroquinolone antimicrobial agents. Antimicrob Agents Chemother (2008) 0.84
Management of febrile neutropenia in the era of bacterial resistance. Ther Adv Infect Dis (2013) 0.82
Impact of outpatient antibiotic use on carriage of ampicillin-resistant Escherichia coli. Antimicrob Agents Chemother (2010) 0.82
Association between Clostridium difficile infection and antimicrobial usage in a large group of English hospitals. Br J Clin Pharmacol (2014) 0.80
Short Term Survival after Admission for Heart Failure in Sweden: Applying Multilevel Analyses of Discriminatory Accuracy to Evaluate Institutional Performance. PLoS One (2016) 0.79
A prospective study on the antimicrobial usage in the medicine department of a tertiary care teaching hospital. J Clin Diagn Res (2013) 0.79
Antibiotic prescribing patterns and hospital admissions with respiratory and urinary tract infections. Eur J Clin Pharmacol (2008) 0.78
Antimicrobial resistance of Escherichia coli isolates from canine urinary tract infections. J Vet Med Sci (2014) 0.77
An antibiotic prescription induces resistance at the individual level more than the group level. J Am Med Dir Assoc (2013) 0.76
Think (Gram) negative! Crit Care (2010) 0.75
Lessons Learned from Surveillance of Antimicrobial Susceptibilities of Pseudomonas aeruginosa at a Large Academic Medical Center. Pharmaceuticals (Basel) (2010) 0.75
Antibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation. Mediterr J Hematol Infect Dis (2017) 0.75
The effect of antibiotic use on prevalence of nosocomial vancomycin-resistant enterococci- an ecologic study. Antimicrob Resist Infect Control (2017) 0.75
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect (2011) 17.47
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect (2012) 4.68
Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital. Clin Infect Dis (2006) 3.64
Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet (1998) 3.29
Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill (2010) 3.22
Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother (1999) 3.16
Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med (1999) 3.08
Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. Clin Infect Dis (2001) 2.94
Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Engl J Med (1999) 2.87
Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013. Euro Surveill (2013) 2.63
Colonization with broad-spectrum cephalosporin-resistant gram-negative bacilli in intensive care units during a nonoutbreak period: prevalence, risk factors, and rate of infection. Crit Care Med (1999) 2.56
Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation (2000) 2.32
Comparison of restriction endonuclease analysis, ribotyping, and pulsed-field gel electrophoresis for molecular differentiation of Clostridium difficile strains. J Clin Microbiol (1994) 2.23
SME-type carbapenem-hydrolyzing class A beta-lactamases from geographically diverse Serratia marcescens strains. Antimicrob Agents Chemother (2000) 2.15
Therapeutic Trial of Methionine in Infective Hepatitis. Br Med J (1945) 1.95
National and regional assessment of the antibacterial soap market: a step toward determining the impact of prevalent antibacterial soaps. Am J Infect Control (2001) 1.94
The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy. Am J Med (2001) 1.86
Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa. Clin Infect Dis (1999) 1.83
Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns. Clin Infect Dis (1997) 1.82
Staphylococcus aureus catheter-associated bacteremia. Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters. Arch Intern Med (1995) 1.64
Erroneous reporting of coagulase-negative Staphylococci as Kocuria spp. by the Vitek 2 system. J Clin Microbiol (2005) 1.58
Risk factors for postoperative mediastinitis due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis (2004) 1.56
Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria. Clin Microbiol Infect (2012) 1.54
Vancomycin-resistant enterococci in intensive care units: high frequency of stool carriage during a non-outbreak period. Arch Intern Med (1999) 1.53
Unexpected hospital-acquired bacteraemia in patients at low risk of bloodstream infection: the role of a heparin drip. J Hosp Infect (2005) 1.52
Comparison of PCR-based approaches to molecular epidemiologic analysis of Clostridium difficile. J Clin Microbiol (1996) 1.46
Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp. Antimicrob Agents Chemother (2001) 1.44
Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center. Antimicrob Agents Chemother (2011) 1.43
A clinical data repository enhances hospital infection control. Proc AMIA Annu Fall Symp (1997) 1.43
Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes. Eur J Clin Microbiol Infect Dis (2007) 1.43
Interventions to control MRSA: high time for time-series analysis? J Antimicrob Chemother (2008) 1.42
Comparison of treatment with imipenem vs. ceftazidime as a predisposing factor for nosocomial acquisition of Stenotrophomonas maltophilia: a historical cohort study. Clin Infect Dis (1997) 1.40
Systems ambiguity and guideline compliance: a qualitative study of how intensive care units follow evidence-based guidelines to reduce healthcare-associated infections. Qual Saf Health Care (2008) 1.34
Risk factors for nosocomial candiduria due to Candida glabrata and Candida albicans. Clin Infect Dis (1999) 1.25
Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected? Clin Microbiol Infect (2012) 1.24
Acinetobacter baumannii: emergence and spread in Israeli hospitals 1997-2002. J Hosp Infect (2005) 1.24
The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis. Arch Intern Med (1999) 1.22
Risk factors for recovery of ampicillin-sulbactam-resistant Escherichia coli in hospitalized patients. Antimicrob Agents Chemother (2000) 1.20
Comparison of culture media for detection of Acinetobacter baumannii in surveillance cultures of critically-ill patients. Eur J Clin Microbiol Infect Dis (2011) 1.17
Extended-spectrum beta-lactamase production is associated with an increase in cell invasion and expression of fimbrial adhesins in Klebsiella pneumoniae. Antimicrob Agents Chemother (2008) 1.16
A cluster of VanD vancomycin-resistant Enterococcus faecium: molecular characterization and clinical epidemiology. J Infect Dis (1999) 1.13
Control group selection is an important but neglected issue in studies of antibiotic resistance. Ann Intern Med (2000) 1.10
Carriage of methicillin-resistant Staphylococcus aureus at hospital admission. Infect Control Hosp Epidemiol (1998) 1.10
Intercontinental spread from Israel to Colombia of a KPC-3-producing Klebsiella pneumoniae strain. Clin Microbiol Infect (2011) 1.08
Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis (1994) 1.05
Assessing risks for a pre-emergent pathogen: virginiamycin use and the emergence of streptogramin resistance in Enterococcus faecium. Lancet Infect Dis (2003) 1.04
Gastrointestinal colonization by KPC-producing Klebsiella pneumoniae following hospital discharge: duration of carriage and risk factors for persistent carriage. Clin Microbiol Infect (2013) 1.03
Unique genes identified in the epidemic extremely drug-resistant KPC-producing Klebsiella pneumoniae sequence type 258. J Antimicrob Chemother (2012) 1.03
Do contact precautions cause depression? A two-year study at a tertiary care medical centre. J Hosp Infect (2011) 1.03
Influence of age, gender, and menstrual cycle on the normal electrogastrogram. Am J Gastroenterol (1996) 1.02
Animal growth promoters: to ban or not to ban? A risk assessment approach. Int J Antimicrob Agents (2004) 1.01
Prevalence and genetic relatedness of community-acquired methicillin-resistant Staphylococcus aureus in Israel. Eur J Clin Microbiol Infect Dis (2006) 1.00
Epidemiological analysis of imipenem-resistant Serratia marcescens in hospitalized patients. J Hosp Infect (1999) 1.00
Clinical implications of stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: a study of 69 patients at 2 university hospitals. Scand J Infect Dis (2000) 0.99
Case-control study to identify factors associated with mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia. Clin Microbiol Infect (2009) 0.99
Benign familial leukopenia and neutropenia in different ethnic groups. Eur J Haematol (1988) 0.98
Rectal swabs are suitable for quantifying the carriage load of KPC-producing carbapenem-resistant Enterobacteriaceae. Antimicrob Agents Chemother (2013) 0.97
Clonal structure, extended-spectrum β-lactamases, and acquired AmpC-type cephalosporinases of Escherichia coli populations colonizing patients in rehabilitation centers in four countries. Antimicrob Agents Chemother (2012) 0.97
Comparative population analysis of Klebsiella pneumoniae strains with extended-spectrum β-lactamases colonizing patients in rehabilitation centers in four countries. Antimicrob Agents Chemother (2013) 0.97
Molecular typing of coagulase-negative staphylococci from blood cultures does not correlate with clinical criteria for true bacteremia. Am J Med (2000) 0.96
Spread of NDM-2-producing Acinetobacter baumannii in the Middle East. J Antimicrob Chemother (2013) 0.96
Clinical isolation and resistance patterns of and superinfection with 10 nosocomial pathogens after treatment with ceftriaxone versus ampicillin-sulbactam. Antimicrob Agents Chemother (2001) 0.96
Diarrhea and quality of life in ambulatory HIV-infected patients. Dig Dis Sci (1996) 0.95
Carriage of methicillin-resistant Staphylococcus aureus on admission to European rehabilitation centres--a prospective study. Clin Microbiol Infect (2012) 0.95
Chlorpromazine and the untreated chronic schizophrenic: a long-term trial. Br J Psychiatry (1967) 0.95
Transmission dynamics of ESBL-producing Escherichia coli clones in rehabilitation wards at a tertiary care centre. Clin Microbiol Infect (2012) 0.94
Reduced susceptibility to chlorhexidine among extremely-drug-resistant strains of Klebsiella pneumoniae. J Hosp Infect (2012) 0.93
A survey on handwashing practices and opinions of healthcare workers. J Hosp Infect (2000) 0.93
Phase I study of a human monoclonal antibody directed against the CD4-binding site of HIV type 1 glycoprotein 120. AIDS Res Hum Retroviruses (1998) 0.92
Clinical significance and antibiotic resistance patterns of Leminorella spp., an emerging nosocomial pathogen. J Clin Microbiol (2000) 0.91
The emergence and dissemination of CTX-M-producing Escherichia coli sequence type 131 causing community-onset bacteremia in Israel. Eur J Clin Microbiol Infect Dis (2012) 0.90
Penicillin skin testing: a way to optimize antibiotic utilization. Am J Med (1999) 0.90
Antimicrobial susceptibility of intra-abdominal gram-negative bacilli from Europe: SMART Europe 2008. Eur J Clin Microbiol Infect Dis (2010) 0.90
Culture-based detection of methicillin-resistant Staphylococcus aureus by a network of European laboratories: an external quality assessment study. Eur J Clin Microbiol Infect Dis (2011) 0.90
Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression. Transplantation (1995) 0.90
Effects of stimulants, anorectics, and related drugs on schedule-controlled behavior. Psychopharmacology (Berl) (1978) 0.89
Gastroduodenal motility and dysmotility: an update on techniques available for evaluation. Am J Gastroenterol (1995) 0.88
Environmental contamination by carbapenem-resistant Enterobacteriaceae. J Clin Microbiol (2012) 0.88
Cost-effectiveness of adding decolonization to a surveillance strategy of screening and isolation for methicillin-resistant Staphylococcus aureus carriers. Clin Microbiol Infect (2010) 0.86
Stool colonization of healthcare workers with selected resistant bacteria. Infect Control Hosp Epidemiol (1998) 0.86
Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Israel: dissemination of global clones and unique features. J Clin Microbiol (2011) 0.85
A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia. Clin Microbiol Infect (2014) 0.85
Pharmacokinetics of F105, a human monoclonal antibody, in persons infected with human immunodeficiency virus type 1. Clin Pharmacol Ther (1996) 0.85
Psychiatric services and the future. A local study in Oxfordshire. Lancet (1973) 0.83
Developing a taxonomy for research in adverse drug events: potholes and signposts. Proc AMIA Symp (2001) 0.83
Protocol for the accelerated detection of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains from blood cultures. Eur J Clin Microbiol Infect Dis (2004) 0.82
SCCmec and spa types of methicillin-resistant Staphylococcus aureus strains in Israel. Detection of SCCmec type V. Eur J Clin Microbiol Infect Dis (2007) 0.82
Methods and recommendations for evaluating and reporting a new diagnostic test. Eur J Clin Microbiol Infect Dis (2012) 0.82
Surgical treatment for Crohn's disease of the fourth part of the duodenum. J R Soc Med (1990) 0.81